Citation Impact
Citing Papers
Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma
2008
Mechanisms of Viral Membrane Fusion and Its Inhibition
2001
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
2007 StandoutScienceNobel
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy
2012 StandoutScienceNobel
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1
2001
Selective Expansion of HIV-1 Envelope Glycoprotein-Specific B Cell Subsets Recognizing Distinct Structural Elements Following Immunization
2009
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice
2018
Heparin-Protein Interactions
2002 Standout
Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes
2002
The Role of the CD4 Receptor versus HIV Coreceptors in Envelope-Mediated Apoptosis in Peripheral Blood Mononuclear Cells
2002
Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein
1999
Nicastrin Functions as a γ-Secretase-Substrate Receptor
2005 StandoutNobel
Evolution of Human and Non-human Primate CC Chemokine Receptor 5 Gene and mRNA
2000
Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo
2008
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Chemokines and HIV–1 second receptors
1996
Host factors and the pathogenesis of HIV-induced disease
1996 Nature
Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor
2003
High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I
2005
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
1998 StandoutNature
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
HIV-1 envelope determinants for cell tropism and chemokine receptor use
1999
Structure of an unliganded simian immunodeficiency virus gp120 core
2005 Nature
Hepatitis C virus entry: Molecular biology and clinical implications
2006
[9] Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry
1997
Structure Modeling of All Identified G Protein–Coupled Receptors in the Human Genome
2006
Cell entry of hepatitis C virus
2006
SNAREpins: Minimal Machinery for Membrane Fusion
1998 StandoutNobel
Core Structure of gp41 from the HIV Envelope Glycoprotein
1997 Standout
Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption
2002
Analysis of the Interaction of Antibodies with a Conserved, Enzymatically Deglycosylated Core of the HIV Type 1 Envelope Glycoprotein 120
1998
In vivo cancer targeting and imaging with semiconductor quantum dots
2004 Standout
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Differences in Chemokine Coreceptor Usage between Genetic Subtypes of HIV-1
1998
C-type Lectins L-SIGN and DC-SIGN Capture and Transmit Infectious Hepatitis C Virus Pseudotype Particles
2004
Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site
2008
Membrane Fusion
2003 StandoutNobel
Super-resolution biomolecular crystallography with low-resolution data
2010 StandoutNatureNobel
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
2009 StandoutNatureNobel
Glycosylation in health and disease
2019
A Blueprint for HIV Vaccine Discovery
2012
Click Chemistry on Azidoproline: High‐Affinity Dual Antagonist for HIV‐1 Envelope Glycoprotein gp120
2005
Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus†
2005
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Mutations in CCR5-Coding Sequences Are Not Associated with SIV Carrier Status in African Nonhuman Primates
1999 StandoutNobel
HIV Type 1 Subtypes, Coreceptor Usage, and CCR5 Polymorphism
1997
Hepatitis C Virus Entry
2007 StandoutNobel
How Do Viruses Enter Cells? The HIV Coreceptors Teach Us a Lesson of Complexity
1997
Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?
2005
Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein
2006
Mutations That Destabilize the gp41 Core Are Determinants for Stabilizing the Simian Immunodeficiency Virus-CPmac Envelope Glycoprotein Complex
2002
Beyond Receptor Expression: The Influence of Receptor Conformation, Density, and Affinity in HIV-1 Infection
2000
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Hepatitis C virus infection: when silence is deception
2003
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
2011 StandoutNatureNobel
HIV fusion and its inhibition
2001
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
1997 StandoutNatureNobel
Making antibody fragments using phage display libraries
1991 StandoutNatureNobel
Novel Insights into Hepatitis C Virus Replication and Persistence
2004
A Critical Site in the Core of the CCR5 Chemokine Receptor Required for Binding and Infectivity of Human Immunodeficiency Virus Type 1
1999
In vivo molecular and cellular imaging with quantum dots
2004
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
2013
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
1998
Partial Purification and Characterization of γ-Secretase from Post-mortem Human Brain
2003
Complement recruitment using bispecific diabodies
1997 StandoutNobel
The antigenic structure of the HIV gp120 envelope glycoprotein
1998 Nature
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Functional Dissection of CCR5 Coreceptor Function through the Use of CD4-Independent Simian Immunodeficiency Virus Strains
1999
gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5
1998
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses
1997
CD81-Dependent Binding of Hepatitis C Virus E1E2 Heterodimers
2003
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
2011 StandoutScienceNobel
Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library.
1990
Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein
1999
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line–adapted HIV-1 Neutralization
1997
Envelope-Dependent, Cyclophilin-Independent Effects of Glycosaminoglycans on Human Immunodeficiency Virus Type 1 Attachment and Infection
2002
Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity
2007
Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes
2000
Frequent Substitution Polymorphisms in African Green Monkey CCR5 Cluster at Critical Sites for Infections by Simian Immunodeficiency Virus SIVagm, Implying Ancient Virus-Host Coevolution
2001 StandoutNobel
CCR5-Mediated Human Immunodeficiency Virus Entry Depends on an Amino-Terminal gp120-Binding Site and on the Conformational Integrity of All Four Extracellular Domains
1999
Coreceptors--Implications for HIV Pathogenesis and Therapy
1997 Science
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120
2002
A Tyrosine-Rich Region in the N Terminus of CCR5 Is Important for Human Immunodeficiency Virus Type 1 Entry and Mediates an Association between gp120 and CCR5
1998
CD81 is an entry coreceptor for hepatitis C virus
2004
Carbohydrate Sulfotransferases of the GalNAc/Gal/GlcNAc6ST Family
2002 StandoutNobel
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I
2006
DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus
2004
Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism
1997
Multiple nonfunctional alleles of CCR5 are frequent in various human populations
2000
Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis
2006
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
2005
Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12
1997
HIV-1–cellular interactions analyzed by single virus tracing
2008
Hepatitis C virus entry: potential receptors and their biological functions
2006
CD4-Induced Conformational Changes in the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein: Consequences for Virus Entry and Neutralization
1998
CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes
2008
Alanine Substitutions of Polar and Nonpolar Residues in the Amino-Terminal Domain of CCR5 Differently Impair Entry of Macrophage- and Dualtropic Isolates of Human Immunodeficiency Virus Type 1
1998
TAK-652 Inhibits CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection In Vitro and Has Favorable Pharmacokinetics in Humans
2005
Ability of the V3 Loop of Simian Immunodeficiency Virus To Serve as a Target for Antibody-Mediated Neutralization: Correlation of Neutralization Sensitivity, Growth in Macrophages, and Decreased Dependence on CD4
2001
Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein
1997
Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors
2007
A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant
2014
Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses
2006
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
Modeling the Structural Basis of Human CCR5 Chemokine Receptor Function: From Homology Model Building and Molecular Dynamics Validation to Agonist and Antagonist Docking
2006
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1
1998
The Fluorescent Toolbox for Assessing Protein Location and Function
2006 StandoutScienceNobel
Spontaneous Mutations in the env Gene of the Human Immunodeficiency Virus Type 1 NDK Isolate Are Associated with a CD4-Independent Entry Phenotype
1998
Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry
1999
Diverse CD81 Proteins Support Hepatitis C Virus Infection
2006 StandoutNobel
Structural insights into key sites of vulnerability on HIV ‐1 Env and influenza HA
2012
Relationships between CD4 Independence, Neutralization Sensitivity, and Exposure of a CD4-Induced Epitope in a Human Immunodeficiency Virus Type 1 Envelope Protein
2001
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies
2008
Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes
2000
Cooperation of Multiple CCR5 Coreceptors Is Required for Infections by Human Immunodeficiency Virus Type 1
2000
Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions
2003
Cu-Catalyzed Azide−Alkyne Cycloaddition
2008 StandoutNobel
Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding
2006
Cell-Mediated Immunity and the Outcome of Hepatitis C Virus Infection
2004
Neutralizing Monoclonal Antibodies Block Human Immunodeficiency Virus Type 1 Infection of Dendritic Cells and Transmission to T Cells
1998 StandoutNobel
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains
1997
Prospects for the Future
2002 StandoutScienceNobel
Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding
2000
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of William C. Olson being referenced
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
2015
Erratum: Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
2017
Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture
2012
Single‐Dose Safety, Pharmacology, and Antiviral Activity of the Human Immunodeficiency Virus (HIV) Type 1 Entry Inhibitor PRO 542 in HIV‐Infected Adults
2000
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
2017
Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
2007
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo
2009
Dissociation kinetics of antigen-antibody interactions: studies on a panel of anti-albumin monoclonal antibodies
1989
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function
2010
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
1996 Nature
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1
2009
A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer
2012
Partial Enzymatic Deglycosylation Preserves the Structure of Cleaved Recombinant HIV-1 Envelope Glycoprotein Trimers
2012
Recombinant CD4‐IgG2 in Human Immunodeficiency Virus Type 1–Infected Children: Phase 1/2 Study
2000
A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120
2006
Mapping the Determinants of the CCR5 Amino-Terminal Sulfopeptide Interaction with Soluble Human Immunodeficiency Virus Type 1 gp120-CD4 Complexes
2001
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
2003
L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus
2004
Oligomeric and Conformational Properties of a Proteolytically Mature, Disulfide-Stabilized Human Immunodeficiency Virus Type 1 gp140 Envelope Glycoprotein
2002
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus
2003
Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140
2001
Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody
1992
Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120
2000
Potent Antitumor Activity of an Auristatin-Conjugated, Fully Human Monoclonal Antibody to Prostate-Specific Membrane Antigen
2006
Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer
1996
Selective Interactions of Polyanions with Basic Surfaces on Human Immunodeficiency Virus Type 1 gp120
2000
Redox-Triggered Infection by Disulfide-Shackled Human Immunodeficiency Virus Type 1 Pseudovirions
2003
A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure
2000
Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1
2002
Evaluating the Immunogenicity of a Disulfide-Stabilized, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1
2005
Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5
1999
Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry
1998
Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures
2011
L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles
2006